Inactive Instrument

News VASOGEN INC. Nasdaq

Stocks

CA92232F2026

End-of-day quote Nasdaq
- ^USD	-

All News

Mentions Relevance

09-10-19	VASOGEN INC : Vasogen Inc. and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger	PR
09-10-15	VASOGEN INC : Vasogen Announces Third Quarter 2009 Results	PR
09-08-17	VASOGEN INC : Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company	PR
09-08-17	VASOGEN INC : Vasogen Receives NASDAQ Notification Related to Minimum Bid Price	PR
09-07-14	VASOGEN INC : Vasogen Announces Second Quarter 2009 Results	PR
-1-11-29	VASOGEN : Announces Third Quarter 2008 Results	PR
-1-11-29	VASOGEN : Announces Second Quarter 2008 Results	PR
-1-11-29	VASOGEN : Provides Corporate Update	PR
-1-11-29	Vasogen : Vasogen Receives NASDAQ Notification Related to Minimum Bid Price	PR
-1-11-29	Vasogen : Vasogen Announces Implementation of Strategic Restructuring Plan	PR
-1-11-29	Vasogen : Vasogen Announces First Quarter 2008 Results	PR
-1-11-29	Vasogen : Vasogen to Webcast its Annual Meeting	PR
-1-11-29	Vasogen : Vasogen Provides Update on ACCLAIM II Program	PR
-1-11-29	Vasogen : Vasogen Provides Update on ACCLAIM II Program	PR
-1-11-29	Vasogen : Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel	PR
-1-11-29	Vasogen Inc : Rodman & Renshaw, LLC Announces Investment Opinion: Rodman & Renshaw, LLC Initiates Coverage of Vasogen Inc. With A Market Outperform Rating	BU
-1-11-29	VASOGEN : Appoints Dr. Eldon Smith Chairman	PR
-1-11-29	VASOGEN : Announces First Quarter 2009 Results	PR
-1-11-29	VASOGEN : Announces 2008 Year-End Results	PR
-1-11-29	VASOGEN : Announces Sale of Patent Application and Provides Corporate Update	PR
-1-11-29	VASOGEN : Complies with NASDAQ Marketplace Rule 4350(c)(1)	PR
-1-11-29	VASOGEN : Provides Corporate Update	PR